EGFR and neoplasm: 2.4. An Inhibitor Targeting EGFR/HER2 and HDAC Synergizes with Doxorubicin to Induce Apoptosis in MPM Cells and Inhibit Tumor Growth in Two Mesothelioma Mouse Models